Augmented phosphorylation of cardiac troponin I in hypertensive heart failure. - Wikidata - wikimedia - TriplyDB

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

http://www.wikidata.org/entity/Q35668835

about

Integration of troponin I phosphorylation with cardiac regulatory networks Top-down proteomics in health and disease: challenges and opportunities Phosphorylation of protein kinase C sites Ser42/44 decreases Ca(2+)-sensitivity and blunts enhanced length-dependent activation in response to protein kinase A in human cardiomyocytes Online Hydrophobic Interaction Chromatography-Mass Spectrometry for Top-Down Proteomics MASH Suite: a user-friendly and versatile software interface for high-resolution mass spectrometry data interpretation and visualization Applying label-free quantitation to top down proteomics.Proteomics in heart failure: top-down or bottom-up?Quantitative proteomics in cardiovascular research: global and targeted strategies Top-down proteomics reveals concerted reductions in myofilament and Z-disc protein phosphorylation after acute myocardial infarction.Cypher/ZASP is a novel A-kinase anchoring protein.Top-down mass spectrometry of cardiac myofilament proteins in health and disease.Independent modulation of contractile performance by cardiac troponin I Ser43 and Ser45 in the dynamic sarcomere.New mass-spectrometry-compatible degradable surfactant for tissue proteomics Dissecting human skeletal muscle troponin proteoforms by top-down mass spectrometry.MASH Suite Pro: A Comprehensive Software Tool for Top-Down Proteomics.A Method for Label-Free, Differential Top-Down Proteomics.Top-down targeted proteomics for deep sequencing of tropomyosin isoforms.The impact of antibody selection on the detection of cardiac troponin I.Myofilament incorporation and contractile function after gene transfer of cardiac troponin I Ser43/45Ala.Functionally conservative substitutions at cardiac troponin I S43/45.The emergence of top-down proteomics in clinical research Mast cells regulate myofilament calcium sensitization and heart function after myocardial infarction.Comprehensive analysis of tropomyosin isoforms in skeletal muscles by top-down proteomics.Effective top-down LC/MS+ method for assessing actin isoforms as a potential cardiac disease marker In-depth proteomic analysis of human tropomyosin by top-down mass spectrometry.Progress in Top-Down Proteomics and the Analysis of Proteoforms.Current trends in magnetic particle enrichment for mass spectrometry-based analysis of cardiovascular protein biomarkers.Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.Top-down Proteomics: Technology Advancements and Applications to Heart Diseases.Top-Down Mass Spectrometry: Proteomics to Proteoforms.Comprehensive Characterization of AMP-Activated Protein Kinase Catalytic Domain by Top-Down Mass Spectrometry Genetically Encoded Biosensors Reveal PKA Hyperphosphorylation on the Myofilaments in Rabbit Heart Failure.Three dimensional liquid chromatography coupling ion exchange chromatography/hydrophobic interaction chromatography/reverse phase chromatography for effective protein separation in top-down proteomics.Top-Down Targeted Proteomics Reveals Decrease in Myosin Regulatory Light-Chain Phosphorylation That Contributes to Sarcopenic Muscle Dysfunction.Characterization of Proteoforms with Unknown Post-translational Modifications Using the MIScore Comprehensive assessment of chamber-specific and transmural heterogeneity in myofilament protein phosphorylation by top-down mass spectrometry.Effective protein separation by coupling hydrophobic interaction and reverse phase chromatography for top-down proteomics.Ultrahigh pressure fast size exclusion chromatography for top-down proteomics.The art of the deal in myofilament modulation of function.Re-configurable, multi-mode contained-electrospray ionization for protein folding and unfolding on the millisecond time scale.

P2860

Q26852120-8551FDF8-2C4A-40EC-824E-6A3CD5382CF1 Q27002139-D55C0EE4-5450-458B-89E8-C87BAEEFF266 Q28239800-AE55AD4A-E112-46E8-94EC-736F3ECA60F0 Q30383142-504A634F-BBEF-4F02-91F7-0698028B129F Q30725379-5A88C2D5-EB33-4A7A-84B2-E7CDA2B9BB37 Q33662342-B5676EE8-F291-4DD2-81CA-2B8EFDC083FE Q33680476-98A172D6-FD1D-49E8-B5F3-63560EBEFB9B Q34156082-BA1296E1-39D1-47AA-851E-FED2E50B032F Q34303423-4AB8CC4B-5134-472D-A8CC-D35DAACF2409 Q34368057-D7A3ED81-A16A-4F50-BE2D-8C5F18BE247E Q34506950-FC201333-4C46-4FF0-AFE2-2BBE8A4AA2E2 Q34995673-9ECACFE9-D9EA-42F3-9559-DA79A1CC9F59 Q35258659-CCC18121-F6B8-40BC-A109-5D8285580039 Q35593909-1DF4C213-4E48-4849-80AE-EFD589147162 Q36539520-DFE0FDC6-DE46-48CF-8BE0-7CBA6C826AE8 Q36649014-AB4CFDF1-FEFD-4BE6-9384-AEFEAB7835DC Q36682535-CCD470B9-6D73-4942-A8FD-0A5D009C9DAC Q36781774-F3784C06-4235-43AB-A91C-0FD3CAE98999 Q36807617-DC97F014-E83A-48E3-B509-381F452E898B Q36984316-C5D305AC-0C26-4FBA-ACFA-D7AA2589431F Q36998685-EAA0F468-61B5-4AAD-8190-9F674495DDC0 Q37047339-8BFC5BB5-6338-4FA7-B0C5-9629F9819D49 Q37114271-681CAA7B-3AD9-4714-B256-5786B6BA6524 Q37136323-6EA6E96E-E4C4-4DC7-A231-F05F0D241BA8 Q37360589-6806074B-2430-4F7B-A2CA-D10B64AC0DC7 Q37730532-5C33FDBF-0AA6-47A6-BD91-95DC0B787331 Q38364469-FC1D5E07-F259-4AD1-919C-4C2B96018582 Q38552059-9AEDC754-2A8E-4B29-A7AA-52C055C308DB Q38905767-7B77CD95-8999-4F0A-BCEA-F81C7656BC27 Q39038792-1001CAF9-FACD-443B-BBA8-6B192E44B1FE Q40406207-880EE119-E72B-4832-87D7-B7049D26260E Q40601692-47E97839-6820-4EB5-A484-3206C9EDA2F2 Q41082825-D2B04673-11F5-495B-A4F2-6855360DBEC8 Q42112173-7A2B25FD-6B26-4A31-B95C-F4C6F6D220EE Q42314966-7794B23D-D6F3-474A-98CA-BD22BEA53450 Q42481044-256DECF5-8752-409B-8E61-2FA57AA3A246 Q42841311-8DE131A4-C325-4C5E-BEC1-6E69CE45BAD1 Q42870571-3A60D41E-A413-4BE9-B90E-F1AE36F07A48 Q43100735-2B91A24E-4B36-4DA6-9F58-F1CC90BFA103 Q46362043-55965C13-772C-4501-8CF6-F12560BDB9F0

P2860

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

http://www.wikidata.org/entity/Q35668835

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

@ast

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

@en

type

label

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

@ast

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

@en

prefLabel

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

@ast

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

@en

P1433

Q35668835-AD9A8398-E7CA-4DED-A246-4B90E6033B8D

P1476

Q35668835-772733EB-42BB-4482-846F-CDF6C092F25F

P2093

Q35668835-08D40144-4176-433C-8CFD-BCD3B06167C5

Q35668835-0C64F590-D1A9-40BB-BAD9-93960193FCD0

Q35668835-12D166DC-EC2F-43D1-8EA1-7E8DE2B927BA

Q35668835-234E1A3B-3205-4C9E-AFE9-CE072EF8CFF3

Q35668835-7077973B-BC6F-48FB-8C6D-BD68F1986F18

Q35668835-984FE7FC-CC27-4132-9BA9-A19979B8A62E

Q35668835-CA4F8F78-A26B-47D0-81D2-97EE5308EC2B

Q35668835-FE4A7360-C6DA-491A-811D-CCEAC49EEFDA

P2860

Q35668835-016F78A9-E5C4-4556-9D94-4A88F916A3B1

Q35668835-02EBB501-B46D-42EC-A229-BC88805C5ECF

Q35668835-077A8D4E-34B0-4916-A121-AC03856A823E

Q35668835-0D9386B9-7C9D-4361-A09A-F9A31C41CE3D

Q35668835-1C999562-843A-4A91-962D-68369FD3448F

Q35668835-1ECBAAAF-9D90-4743-8B34-15E6B003C4E4

Q35668835-22FE4406-9879-4D1E-A9DA-7E35E7C9BEE0

Q35668835-269C1359-85D5-47ED-B31A-EFF92D43170F

Q35668835-2D7CB35F-AB66-42BC-9D64-72E7B44FDDE0

Q35668835-2EE6D837-CC47-47CC-8F39-75A4D22E8558

P304

Q35668835-AD905107-5BA9-46EB-9D41-3C19529C8A5A

P31

Q35668835-43BF4162-FE8D-49AC-BF55-A1619DDFBE7E

P356

Q35668835-75FCFB44-0650-4B4E-BEF4-0DF2E1462BE9

P407

Q35668835-22FA6A6E-0856-40FB-8ED7-46FBE4724CF7

P433

Q35668835-DEB1CCD7-433C-4350-880E-D6395780BEA8

P478

Q35668835-21953E3E-813F-4404-9D15-6288B7F727B9

P577

Q35668835-AC130928-5B10-474D-8B8D-B6E83664DDE9

P698

Q35668835-87565F1B-567B-4C3E-886D-FFFCE0C07600

P921

Q35668835-0BF26141-B74A-4273-B174-A3D0C9FC2FB4

Q35668835-85BF5B1E-88A4-442B-BFA1-C93444AF7433

P932

Q35668835-8B0B9975-3F05-4F1A-B111-7645CD9AA0F8

P356

JBC.M111.293258

P1433

Journal of Biological Chemistry

P1476

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

@en

P2093

C Amelia Sumandea

http://www.w3.org/2001/XMLSchema#string

C William Balke

http://www.w3.org/2001/XMLSchema#string

Jiang Zhang

http://www.w3.org/2001/XMLSchema#string

Marius P Sumandea

http://www.w3.org/2001/XMLSchema#string

Mary L Garcia-Cazarin

http://www.w3.org/2001/XMLSchema#string

Xintong Dong

http://www.w3.org/2001/XMLSchema#string

Yi-Chen Chen

http://www.w3.org/2001/XMLSchema#string

Ying Ge

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form

Top-down mass spectrometry of a 29-kDa protein for characterization of any posttranslational modification to within one residue

Global assessment of combinatorial post-translational modification of core histones in yeast using contemporary mass spectrometry. LYS4 trimethylation correlates with degree of acetylation on the same H3 tail.

Role of troponin I phosphorylation in protein kinase C-mediated enhanced contractile performance of rat myocytes

Development of a strain of spontaneously hypertensive rats

Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins

Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity

Phosphorylation of the inhibitor component of troponin by phosphorylase kinase

Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo

Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure

P304

848-857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M111.293258

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22052912

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

3256890

http://www.w3.org/2001/XMLSchema#string